Skip Navigation

Japanese Journal of Clinical Oncology 2008 38(4):250-258; doi:10.1093/jjco/hyn019
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Ueda, S.
Right arrow Articles by Mochizuki, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ueda, S.
Right arrow Articles by Mochizuki, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Author (2008). Published by Oxford University Press. All rights reserved

Clinicopathological and Prognostic Relevance of Uptake Level using 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) in Primary Breast Cancer

Shigeto Ueda1, Hitoshi Tsuda2, Hideki Asakawa1, Takashi Shigekawa3, Kazuhiko Fukatsu4, Nobuo Kondo5, Mikio Yamamoto5, Yukihiro Hama6, Katsumi Tamura6, Jiro Ishida6, Yoshiyuki Abe6 and Hidetaka Mochizuki1

1 Department of Surgery, National Defense Medical College, Tokorozawa, Saitama
2 Department of Basic Pathology, National Defense Medical College, Tokorozawa, Saitama
3 Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan
4 Department of Basic Traumatology, National Defense Medical College, Tokorozawa, Saitama
5 Department of Biochemistry, National Defense Medical College, Tokorozawa, Saitama
6 Tokorozawa PET diagnostic Imaging clinic, Tokorozawa, Saitama

For reprints and all correspondence: Hitoshi Tsuda, Department of Basic Pathology, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan. E-mail: htsuda{at}ndmc.ac.jp

Received January 13, 2008; accepted February 21, 2008

Objective: Using integrated 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT), the clinical significance of 18F-FDG uptake was evaluated in patients with primary breast cancer.

Methods: Clinicopathological correlation with the level of maximum standardized uptake values (SUV) 60 min obtained from preoperative 18F-FDG PET/CT were examined in 152 patients with primary breast cancer. The prognostic impact of the level of SUV was explored using simulated prognosis derived from computed program Adjuvant! in 136 (89%) patients with invasive ductal carcinoma (IDC).

Results: High SUV level was significantly correlated with tumor invasive size (≤2 cm) (P <0.0001), higher score of nuclear grade (P <0.0001), nuclear atypia (P <0.0001) and mitosis counts (P <0.0001), negative hormone receptor status (P = 0.001), high score of c-erbB-2 expression (P = 0.006), lymph node metastasis (P = 0.002), and IDC in comparison with invasive lobular carcinoma (P = 0.004). Multivariate analyses showed tumor invasive size, nuclear grade and estrogen receptor negativity were significantly correlated with SUV in primary breast cancer (P <0.0001,<0.0001, and <0.012, respectively), and nuclear grade was significantly correlated with SUV in tumors of invasive size 2 cm or less (P <0.0001). Tumors with high SUV (cutoff value 4.0) showed higher relapse and mortality rate compared to those with low SUV (P <0.0001).

Conclusions: High uptake of 18F-FDG would be predictive of poor prognosis in patients with primary breast cancer, and aggressive features of cancer cells in patients with early breast cancer. 18F-FDG PET/CT could be a useful tool to pretherapeutically predict biological characteristics and baseline risk of breast cancer.

Key Words: breast cancer • 18F-FDG • PET/CT • SUV • prognosis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
JNMHome page
H. Jadvar, A. Alavi, and S. S. Gambhir
18F-FDG Uptake in Lung, Breast, and Colon Cancers: Molecular Biology Correlates and Disease Characterization
J. Nucl. Med., November 1, 2009; 50(11): 1820 - 1827.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K. McLarty, A. Fasih, D. A. Scollard, S. J. Done, D. C. Vines, D. E. Green, D. L. Costantini, and R. M. Reilly
18F-FDG Small-Animal PET/CT Differentiates Trastuzumab-Responsive from Unresponsive Human Breast Cancer Xenografts in Athymic Mice
J. Nucl. Med., November 1, 2009; 50(11): 1848 - 1856.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
N. Taira, S. Ohsumi, D. Takabatake, F. Hara, S. Takashima, K. Aogi, S. Takashima, T. Inoue, S. Sugata, and R. Nishimura
Determination of Indication for Sentinel Lymph Node Biopsy in Clinical Node-negative Breast Cancer Using Preoperative 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging
Jpn. J. Clin. Oncol., January 1, 2009; 39(1): 16 - 21.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.